JPS647047B2 - - Google Patents

Info

Publication number
JPS647047B2
JPS647047B2 JP56208608A JP20860881A JPS647047B2 JP S647047 B2 JPS647047 B2 JP S647047B2 JP 56208608 A JP56208608 A JP 56208608A JP 20860881 A JP20860881 A JP 20860881A JP S647047 B2 JPS647047 B2 JP S647047B2
Authority
JP
Japan
Prior art keywords
nicardipine
methyl methacrylate
spherical granules
coated
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56208608A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58116414A (ja
Inventor
Takashi Sonobe
Hiromitsu Kawada
Masayoshi Ariga
Tadayoshi Oomura
Satoru Yonetani
Chiharu Yamada
Yukio Kubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP56208608A priority Critical patent/JPS58116414A/ja
Priority to MX82101116U priority patent/MX7567E/es
Priority to AT0460682A priority patent/AT386743B/de
Priority to GR70132A priority patent/GR77096B/el
Priority to CA000418228A priority patent/CA1200494A/en
Priority to ES518487A priority patent/ES518487A0/es
Priority to IT68503/82A priority patent/IT1200966B/it
Priority to PT76023A priority patent/PT76023B/pt
Priority to KR8205782A priority patent/KR860001147B1/ko
Publication of JPS58116414A publication Critical patent/JPS58116414A/ja
Priority to US07/013,326 priority patent/US4758437A/en
Priority claimed from US07/013,326 external-priority patent/US4758437A/en
Publication of JPS647047B2 publication Critical patent/JPS647047B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP56208608A 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法 Granted JPS58116414A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP56208608A JPS58116414A (ja) 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法
MX82101116U MX7567E (es) 1981-12-23 1982-12-16 Procedimiento para recubrir nicardipina de accion prolongada
AT0460682A AT386743B (de) 1981-12-23 1982-12-20 Verfahren zur herstellung einer langwirkenden nicardipinzubereitung
GR70132A GR77096B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-12-23 1982-12-21
CA000418228A CA1200494A (en) 1981-12-23 1982-12-21 Process of producing composition for long acting nicardipine preparation
ES518487A ES518487A0 (es) 1981-12-23 1982-12-22 Un procedimiento para producir una composicion para un preparado de accion prolongada de nicardipina.
IT68503/82A IT1200966B (it) 1981-12-23 1982-12-22 Composizione per preparati di nicardipina a lunga azione in forma di granuli sferici e procedimento per la produzione della composizione
PT76023A PT76023B (en) 1981-12-23 1982-12-22 A process of producing composition for long acting nicardipine preparation
KR8205782A KR860001147B1 (ko) 1981-12-23 1982-12-23 지속성 니카르디핀 제제용 조성물의 제조방법
US07/013,326 US4758437A (en) 1981-12-23 1987-02-11 Composition for long acting nicardipine preparation and process of producing the composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56208608A JPS58116414A (ja) 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法
US07/013,326 US4758437A (en) 1981-12-23 1987-02-11 Composition for long acting nicardipine preparation and process of producing the composition

Publications (2)

Publication Number Publication Date
JPS58116414A JPS58116414A (ja) 1983-07-11
JPS647047B2 true JPS647047B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-07

Family

ID=26516929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56208608A Granted JPS58116414A (ja) 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法

Country Status (1)

Country Link
JP (1) JPS58116414A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
JPS61148114A (ja) * 1984-11-15 1986-07-05 Teijin Ltd ニフエジピンの顆粒剤
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
NO883326L (no) * 1987-08-11 1989-02-13 Bayer Ag Dhp-retard-tilberedning.
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
JPH0667824B2 (ja) * 1988-03-30 1994-08-31 友昭 福田 マイクロカプセルの製造方法
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
TW212139B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
EP1027887B1 (en) * 1999-02-10 2008-08-13 Pfizer Products Inc. Matrix controlled release device
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
JPS58116414A (ja) 1983-07-11

Similar Documents

Publication Publication Date Title
US6627223B2 (en) Timed pulsatile drug delivery systems
US5112621A (en) Sustained release pharmaceutical composition of diltiazem
US6270805B1 (en) Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
JP3194974B2 (ja) 標的制御釈放薬剤
KR100316206B1 (ko) 모르핀의염을함유하는방출조절식제제
JP4907765B2 (ja) 経口医薬パルス放出剤形
JP2518882B2 (ja) 被覆膜及びそれから調製された組成物
CA2473200C (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
AU674175B2 (en) Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o- methyl-oxime
EP0386967A2 (en) A drug-release controlling coating material for long acting formulations
JP2001522874A (ja) オメプラゾールの配合物
US20030185887A1 (en) Controlled release oral dosage form of beta-adrenergic blocking agents
CZ296964B6 (cs) Farmaceutické formulace tramadolu v násobných jednotkách a zpusob jejich výroby
JP2003504324A (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
JP2010163447A (ja) ミルナシプランの持続性放出を伴うガレヌス製剤形態
JPS647047B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2000932C (en) Oral pharmaceutical controlled release multiple unit dosage form
JPH0621066B2 (ja) ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
PL192950B1 (pl) Wielocząstkowa postać farmaceutyczna o opóźnionym i stopniowym uwalnianiu, oraz sposób jej wytwarzania
JP2000080028A (ja) 長持続時間を有するシサプリドの経口剤形
JP2000053563A (ja) 苦味がマスクされた速放性細粒剤
JP2000212085A (ja) オメプラゾ―ル又はその他類似物を含有する高安定性経口医薬製剤及びその製法
EP1334723A1 (en) Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2- 2- 4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
CA2547398A1 (en) Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
JPS615010A (ja) 水素添加麦角アルカロイド徐放性製剤及びその製法

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154